Saran Saund - Chief Business Officer at Oncotelic Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Issuer Symbol
OTLC on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Saran Saund since 30 Dec 2024

Holdings reported by Saran Saund for Oncotelic Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,457,480 $427,894 $0.026 08 Jul 2021 Direct
Stock Options 675,000 03 Sep 2021 Direct Common Stock
Series A Convertible Preferred Stock 0 31 Mar 2021 Direct Common Stock

Transactions reported by Saran Saund for Oncotelic Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.